A Phase III Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain
Status:
Recruiting
Trial end date:
2024-01-30
Target enrollment:
Participant gender:
Summary
PRF-110 is a viscous, yellowish clear oily solution of ropivacaine intended for
administration into surgical sites to provide post-operative analgesia. The pharmacokinetic
profile for PRF-110 suggests that its effect could last up to 72 hours. This is A Phase 3,
Randomized, Double-Blind, Saline Placebo- and Active-Controlled, Multicenter Study to
Evaluate the Analgesic Efficacy and Safety of Intra-operative Administration of PRF-110
Following Unilateral Bunionectomy